ENDRA Life Sciences Operating Income

ENDRA Life Sciences posts a operating income of $0 as of March 2026. That compares with $2.7M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, ENDRA Life Sciences's operating income was $2.7M. The latest reading is $0 — a 100.0% year-over-year decrease (period ending March 2026). Use the history and growth charts on this page for a longer lookback.

Operating Income is one piece of ENDRA Life Sciences's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NDRA's operating income usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; ENDRA Life Sciences's other metric pages and overview cover the third.

Judging ENDRA Life Sciences against Technology peers is usually better than using a market-wide rule of thumb. Business models inside Technology are more comparable, which makes gaps in operating income easier to interpret. Start with $0 here, then scan peer and history charts to see if the gap is persistent.